TAM
Trust Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.32M | Hold |
2,962
| – | – | 0.1% | 76 |
|
2025
Q1 | $1.44M | Buy |
2,962
+22
| +0.7% | +$10.7K | 0.12% | 67 |
|
2024
Q4 | $1.18M | Hold |
2,940
| – | – | 0.09% | 79 |
|
2024
Q3 | $1.37M | Hold |
2,940
| – | – | 0.11% | 67 |
|
2024
Q2 | $1.38M | Hold |
2,940
| – | – | 0.12% | 65 |
|
2024
Q1 | $1.23M | Hold |
2,940
| – | – | 0.11% | 73 |
|
2023
Q4 | $1.2M | Hold |
2,940
| – | – | 0.12% | 69 |
|
2023
Q3 | $1.02M | Hold |
2,940
| – | – | 0.11% | 72 |
|
2023
Q2 | $1.03M | Hold |
2,940
| – | – | 0.11% | 73 |
|
2023
Q1 | $926K | Buy |
2,940
+54
| +2% | +$17K | 0.1% | 78 |
|
2022
Q4 | $833K | Hold |
2,886
| – | – | 0.1% | 80 |
|
2022
Q3 | $836K | Buy |
2,886
+211
| +8% | +$61.1K | 0.11% | 73 |
|
2022
Q2 | $754K | Buy |
2,675
+119
| +5% | +$33.5K | 0.11% | 77 |
|
2022
Q1 | $667K | Buy |
2,556
+60
| +2% | +$15.7K | 0.08% | 95 |
|
2021
Q4 | $548K | Hold |
2,496
| – | – | 0.07% | 108 |
|
2021
Q3 | $453K | Buy |
2,496
+167
| +7% | +$30.3K | 0.06% | 122 |
|
2021
Q2 | $470K | Buy |
2,329
+240
| +11% | +$48.4K | 0.06% | 112 |
|
2021
Q1 | $449K | Buy |
2,089
+372
| +22% | +$80K | 0.06% | 109 |
|
2020
Q4 | $406K | Buy |
1,717
+410
| +31% | +$96.9K | 0.06% | 100 |
|
2020
Q3 | $356K | Buy |
1,307
+589
| +82% | +$160K | 0.06% | 74 |
|
2020
Q2 | $208K | Buy |
+718
| New | +$208K | 0.04% | 71 |
|